Granted Patent
B2
US 12,310,951 · App. 18/440,652 · Granted May 27, 2025
Methods of administering anti-fibrotic therapy
Inventors:
Lin Pan (San Francisco, CA); Dorothy Sze-Wing Cheung (San Francisco, CA); Jeffrey Mark Harris (San Francisco, CA); Indiana Strombom (San Francisco, CA)
Assignee:
Genentech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present disclosure relates to methods of administering Compound I for treating fibrotic disorders, inflammatory disorders or autoimmune disorders.
Claims (2)
1. A method of administering Compound I to treat a subject suffering from a fibrotic disorder said method comprising
increasing the maximal plasma concentration (C max ) or the extent of absorption (AUC 0-t or AUC 0-∞ ) of Compound I wherein the C max or AUC of Compound I with food is increased compared to the C max or AUC of the same amount of Compound I administered without food.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 25, 2024
From: INTERMUNE, INC.
To: GENENTECH, INC.
Reel/Frame 068698/0708 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 14, 2024
From: PAN, LIN; CHEUNG, DOROTHY SZE-WING; HARRIS, JEFFREY MARK; STROMBOM, INDIANA
To: GENENTECH, INC.
Reel/Frame 066457/0911 →